The global thrombectomy devices market grew at a CAGR of around 5% during 2015-2020. Looking forward, the market is expected to exhibit moderate growth during 2021-2026. We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Thrombectomy devices offer various benefits in surrogate endpoints, such as infarct size reduction, biomarker analysis, ST-segment resolution and angiographic thrombolysis in myocardial infarction (TIMI) flow. These devices reduce blood loss and damage caused to the vessel wall during a procedure. Thrombectomy devices are widely available in several sizes and diameters, depending on the affected area. As a result, they find widespread application in treating blood clots present in arteries, veins and capillaries. They are also utilized to treat pulmonary embolism and peripheral arterial ailments.
Request Free Sample Report: https://www.imarcgroup.com/thrombectomy-devices-market/requestsample
The increasing prevalence of chronic diseases on account of sedentary consumer lifestyles with the rising consumption of junk food, tobacco, and alcohol, is primarily driving the growth of the thrombectomy devices market. Furthermore, the growing geriatric population, along with the escalating demand for minimally invasive (MI) procedures and upgrading healthcare infrastructures across various countries, are also augmenting the market growth. Additionally, several key manufacturers are increasingly investing in R&D activities to introduce technologically-advanced thrombectomy devices, which, in turn, is creating a positive outlook for the global market. Apart from this, favorable medical reimbursements and rising preferences of these devices by surgeons for performing image-guided surgeries are projected to further augment the market growth in the coming years.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/thrombectomy-devices-market
List of Key Companies Covered in this Market Report:
- Argon Medical Devices Inc.
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Johnson & Johnson
- Medtronic Plc
- Penumbra Inc.
- Spectranetics Corporation (Koninklijke Philips N.V.)
- Stryker Corporation
- Teleflex Incorporated
- Terumo Corporation.
Breakup by Product Type:
- Aspiration Thrombectomy Devices
- Mechanical Thrombectomy Devices
- Ultrasonic Thrombectomy Devices
Breakup by Application:
- Peripheral Vascular
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Surgical Centers
Breakup by Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800